LadRx Corp. (LADX)
0.11
+0.08
(+266.67%)
USD |
OTCM |
Feb 24, 16:00
LadRx Research and Development Expense (Quarterly) : 0.0288M for March 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 23.60M |
| Curis, Inc. | 6.432M |
| Plus Therapeutics, Inc. | 2.436M |
| Windtree Therapeutics, Inc. | 1.537M |
| Enzon Pharmaceuticals, Inc. | -- |